Literature DB >> 16651621

Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes.

Gudrun Szalay1, Silke Meiners, Antje Voigt, Jörg Lauber, Christian Spieth, Nora Speer, Martina Sauter, Ulrike Kuckelkorn, Andreas Zell, Karin Klingel, Karl Stangl, Reinhard Kandolf.   

Abstract

A growing body of evidence indicates that viral infections of the heart contribute to ongoing myocarditis and dilated cardiomyopathy. Murine models of coxsackievirus B3 (CVB3)-induced myocarditis mimic the human disease and allow identification of susceptibility factors that modulate the course of viral myocarditis. Susceptible mouse strains develop chronic myocarditis on the basis of restricted viral replication, whereas resistant strains recover after successful virus elimination. In comparative whole-genome microarray analyses of infected hearts, several genes involved in the processing and presentation of viral epitopes were found to be uniformly up-regulated in acutely CVB3-infected susceptible mice compared with resistant animals. In particular, expression of the catalytic subunits LMP2, LMP7, and MECL-1, immunoproteasome proteins important in the generation of major histocom-patibility complex (MHC) class I-restricted peptides, was clearly enhanced in the susceptible host. Increased expression resulted in enhanced formation of immunoproteasomes and altered proteolytic activities of proteasomes in the heart. This was accompanied by a concerted up-regulation of the antigen-presenting machinery in susceptible mice. Thus, we propose that increased formation of immunoproteasomes in susceptible mice affects the generation of antigenic peptides and the subsequent T-cell-mediated immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16651621      PMCID: PMC1606581          DOI: 10.2353/ajpath.2006.050865

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  51 in total

1.  Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells.

Authors:  S Morel; F Lévy; O Burlet-Schiltz; F Brasseur; M Probst-Kepper; A L Peitrequin; B Monsarrat; R Van Velthoven; J C Cerottini; T Boon; J E Gairin; B J Van den Eynde
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 2.  Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome.

Authors:  B J Van den Eynde; S Morel
Journal:  Curr Opin Immunol       Date:  2001-04       Impact factor: 7.486

3.  Host gene regulation during coxsackievirus B3 infection in mice: assessment by microarrays.

Authors:  L A Taylor; C M Carthy; D Yang; K Saad; D Wong; G Schreiner; L W Stanton; B M McManus
Journal:  Circ Res       Date:  2000-08-18       Impact factor: 17.367

Review 4.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

5.  MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.

Authors:  A J Sijts; S Standera; R E Toes; T Ruppert; N J Beekman; P A van Veelen; F A Ossendorp; C J Melief; P M Kloetzel
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

6.  Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of Mammalian proteasomes.

Authors:  Silke Meiners; Dirk Heyken; Andrea Weller; Antje Ludwig; Karl Stangl; Peter-M Kloetzel; Elke Krüger
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

7.  Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 alpha/beta, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope.

Authors:  K Schwarz; M van Den Broek; S Kostka; R Kraft; A Soza; G Schmidtke; P M Kloetzel; M Groettrup
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

8.  beta2-microglobulin-associated regulation of interferon-gamma and virus-specific immunoglobulin G confer resistance against the development of chronic coxsackievirus myocarditis.

Authors:  Karin Klingel; Jens-Jörg Schnorr; Martina Sauter; Gudrun Szalay; Reinhard Kandolf
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

9.  Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.

Authors:  A Sijts; M Camps; R Offringa; C Melief; P M Kloetzel; F Ossendorp
Journal:  J Exp Med       Date:  2000-08-21       Impact factor: 14.307

Review 10.  Viral mechanisms of immune evasion.

Authors:  A Alcami; U H Koszinowski
Journal:  Immunol Today       Date:  2000-09
View more
  19 in total

1.  Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis.

Authors:  Pippa F Cosper; Pamela A Harvey; Leslie A Leinwand
Journal:  Am J Pathol       Date:  2012-10-08       Impact factor: 4.307

2.  Proteome dynamics and proteome function of cardiac 19S proteasomes.

Authors:  Ding Wang; Chenggong Zong; Myong-chul Koag; Yueju Wang; Oliver Drews; Caiyun Fang; Sarah B Scruggs; Peipei Ping
Journal:  Mol Cell Proteomics       Date:  2011-02-25       Impact factor: 5.911

Review 3.  Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies.

Authors:  Oliver Drews; Heinrich Taegtmeyer
Journal:  Antioxid Redox Signal       Date:  2014-10-01       Impact factor: 8.401

Review 4.  The role of the proteasome in heart disease.

Authors:  Yi-Fan Li; Xuejun Wang
Journal:  Biochim Biophys Acta       Date:  2010-09-15

5.  Differential interferon responses enhance viral epitope generation by myocardial immunoproteasomes in murine enterovirus myocarditis.

Authors:  Sandra Jäkel; Ulrike Kuckelkorn; Gudrun Szalay; Michael Plötz; Kathrin Textoris-Taube; Elisa Opitz; Karin Klingel; Stefan Stevanovic; Reinhard Kandolf; Katja Kotsch; Karl Stangl; Peter M Kloetzel; Antje Voigt
Journal:  Am J Pathol       Date:  2009-07-09       Impact factor: 4.307

6.  Interferon-dependent immunoproteasome activity during mouse adenovirus type 1 infection.

Authors:  Mary K McCarthy; Danielle H Malitz; Caitlyn T Molloy; Megan C Procario; Kaitlyn E Greiner; Luna Zhang; Ping Wang; Sharlene M Day; Saul R Powell; Jason B Weinberg
Journal:  Virology       Date:  2016-08-22       Impact factor: 3.616

7.  Bioinformatics multivariate analysis determined a set of phase-specific biomarker candidates in a novel mouse model for viral myocarditis.

Authors:  Seiichi Omura; Eiichiro Kawai; Fumitaka Sato; Nicholas E Martinez; Ganta V Chaitanya; Phoebe A Rollyson; Urska Cvek; Marjan Trutschl; J Steven Alexander; Ikuo Tsunoda
Journal:  Circ Cardiovasc Genet       Date:  2014-07-16

8.  PAR-1 contributes to the innate immune response during viral infection.

Authors:  Silvio Antoniak; A Phillip Owens; Martin Baunacke; Julie C Williams; Rebecca D Lee; Alice Weithäuser; Patricia A Sheridan; Ronny Malz; James P Luyendyk; Denise A Esserman; JoAnn Trejo; Daniel Kirchhofer; Burns C Blaxall; Rafal Pawlinski; Melinda A Beck; Ursula Rauch; Nigel Mackman
Journal:  J Clin Invest       Date:  2013-02-08       Impact factor: 14.808

9.  Connective tissue growth factor: a crucial cytokine-mediating cardiac fibrosis in ongoing enterovirus myocarditis.

Authors:  Christine Lang; Martina Sauter; Gudrun Szalay; Giorgia Racchi; Gabriele Grassi; Giuseppe Rainaldi; Alberto Mercatanti; Florian Lang; Reinhard Kandolf; Karin Klingel
Journal:  J Mol Med (Berl)       Date:  2007-09-11       Impact factor: 4.599

10.  Cytokine-induced oxidative stress in cardiac inflammation and heart failure-how the ubiquitin proteasome system targets this vicious cycle.

Authors:  Antje Voigt; Anna Rahnefeld; Peter M Kloetzel; Elke Krüger
Journal:  Front Physiol       Date:  2013-03-06       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.